FOXO TECHNOLOGIES INC. Increase (Decrease) in Reinsurance Recoverable
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Reinsurance Recoverable of -$18.57 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReinsuranceRecoverable · last filed 2025-04-15
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance recoverable for the quarter ending 2023-12-31 was -$430.00.
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance recoverable for fiscal 2023 was -$18.57M.
| Period end | Increase (Decrease) in Reinsurance Recoverable 3 month | Increase (Decrease) in Reinsurance Recoverable 9 month | Increase (Decrease) in Reinsurance Recoverable 12 month |
|---|---|---|---|
| 2023-12-31 | -$430.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$18.57M 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$18.57M 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |